{"id":11402322,"date":"2026-07-13T23:23:06","date_gmt":"2026-07-13T20:23:06","guid":{"rendered":"https:\/\/nostylelike.net\/product\/avastin-400mg-16ml-bevacizumab\/"},"modified":"2026-08-27T14:19:15","modified_gmt":"2026-08-27T11:19:15","slug":"avastin-bevacizumab-400mg-16ml","status":"publish","type":"product","link":"https:\/\/nostylelike.net\/en\/product\/avastin-bevacizumab-400mg-16ml\/","title":{"rendered":"Avastin 400mg\/16ml Bevacizumab | Colorectal Cancer Treatment"},"content":{"rendered":"
\n

Quick Answer: What Is Avastin?<\/h2>\n

Avastin<\/strong> (bevacizumab) is a targeted therapy \u2014 a laboratory-made antibody, not traditional chemotherapy \u2014 most established in treating metastatic colorectal cancer, where it is combined with standard chemotherapy regimens. It also has approved uses in certain lung, kidney, ovarian, and cervical cancers, and specific brain tumors, depending on your oncologist’s assessment. This 400mg\/16ml vial is administered exclusively as a hospital or oncology-center intravenous infusion, on a schedule and in combinations determined entirely by your treating oncology team.<\/p>\n<\/div>\n

Key Facts About Avastin<\/h2>\n\n\n\n\n\n\n\n\n\n
Product Name<\/th>\nAvastin (Bevacizumab) 400mg\/16ml Vial<\/td>\n<\/tr>\n
Drug Class<\/th>\nMonoclonal antibody \u2014 anti-angiogenic targeted therapy<\/td>\n<\/tr>\n
Common Uses<\/th>\nMetastatic colorectal cancer (with chemotherapy), certain lung, kidney, ovarian, cervical cancers, some brain tumors<\/td>\n<\/tr>\n
Administration<\/th>\nIntravenous infusion, hospital\/oncology center only<\/td>\n<\/tr>\n
Typical Combination<\/th>\nGiven alongside standard chemotherapy regimens, per protocol<\/td>\n<\/tr>\n
Monitoring<\/th>\nBlood pressure, urine protein, and wound-healing status before treatment<\/td>\n<\/tr>\n
Prescription Status<\/th>\nPrescription only \u2014 hospital\/oncology administration exclusively<\/td>\n<\/tr>\n
Price in Egypt<\/th>\n23,529 EGP per vial<\/td>\n<\/tr>\n<\/table>\n

\"avastin<\/p>\n

How Avastin Works \u2014 A Different Strategy Than Chemotherapy<\/h2>\n

Traditional chemotherapy attacks cancer cells directly. Avastin takes a different approach entirely: tumors, once they grow beyond a small size, need to build their own blood supply to survive \u2014 a process called angiogenesis, driven by a signaling protein called VEGF. Bevacizumab is an antibody engineered specifically to bind and neutralize VEGF, cutting off the tumor’s ability to recruit new blood vessels. Starved of the oxygen and nutrients new vessels would supply, tumor growth slows, which is why Avastin is typically combined with chemotherapy that attacks the cancer cells directly \u2014 the two mechanisms work as a coordinated strategy rather than duplicating each other.<\/p>\n

What Treatment Involves<\/h2>\n